Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.580
-0.100 (-5.95%)
At close: Apr 28, 2026, 4:00 PM EDT
1.530
-0.050 (-3.16%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Estrella Immunopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Selling, General & Admin | 2.81 | 2.44 | 3.2 | 0.66 | 0.3 | |
| Research & Development | 10.25 | 6.41 | 4.11 | 10.45 | 1.39 | |
| Operating Expenses | 13.06 | 8.85 | 7.31 | 11.11 | 1.69 | |
| Operating Income | -13.06 | -8.85 | -7.31 | -11.11 | -1.69 | |
| Pretax Income | -13.06 | -8.85 | -7.31 | -11.11 | -1.69 | |
| Income Tax Expense | 0 | 0 | 0 | - | - | |
| Net Income | -13.06 | -8.85 | -7.31 | -11.11 | -1.69 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | -0.61 | |
| Net Income to Common | -13.06 | -8.85 | -7.31 | -11.11 | -1.07 | |
| Shares Outstanding (Basic) | 37 | 36 | 27 | 0 | - | |
| Shares Outstanding (Diluted) | 37 | 36 | 27 | 0 | - | |
| Shares Change (YoY) | 1.63% | 33.68% | 8764.81% | - | - | |
| EPS (Basic) | -0.35 | -0.24 | -0.27 | -36.35 | - | |
| EPS (Diluted) | -0.35 | -0.24 | -0.27 | -36.35 | - | |
| EBIT | -13.06 | -8.85 | -7.31 | -11.11 | -1.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.